Healthcare’s Once-in-a-Generation Disruption

The cost of healthcare in the United States continues to rise and the availability continues to decline. Healthcare spending accounts for 18% of U.S. GDP, and the costs in the U.S. are the highest in the world, increasing 130% in just the last decade. With this complexity comes an opportunity for entrepreneurs, innovators, and investors. iSelect is focused on finding technologies and innovations that reduce costs, increase accessibility, and improve quality of care.

Our Companies | Our Network | Join Our Network | News

iSelect Portfolio Companies

iSelect focuses on early-stage healthcare companies that are poised to help push the next healthcare revolution forward. We deliberately invest in companies that can make a positive impact on our society, as well as on the bottom line.

Neuros Medical, Inc.

Neuros Medical, a medical device company, develops an electrical nerve block to treat chronic pain for conditions including neuroma/residual limb pain and chronic post-surgical pain. Learn more…

Company Website

Cocoon Biotech, Inc.

Fibroin is an insoluble protein that is responsible for silk’s structure and tensile strength. Additional physical properties include tunable viscosity, anti-inflammatory, and wound healing attributes. Cocoon’s fibroin is expected to yield substantial improvements in use-cases such as bio-preservatives, drug or small/molecule delivery, natural lubricants, and hydrogels across numerous industries including human and animal health, agriculture, and consumer products. Learn more…

Company Website

Nix, Inc.

Nix is developing a wearable, single-use patch that monitors hydration in real-time, without the need for a power-source or companion device/app. Learn more…

Company Website

MOBILion Systems

MOBILion Systems Inc. has developed ion mobility technology that can separate and identify previously undetectable, clinically significant molecules within minutes, enabling far more accurate disease diagnosis, biomarker discovery, drug discovery, and clinical trial design among other potential applications. Learn more…

Company Website

Shield Bio

Shield Bio is enabling 3rd generation sequencing to more rapidly and cost effectively diagnose and treat infectious disease while fighting antimicrobial resistance. Learn more…

Company Website

Molecular Assemblies

Molecular Assemblies is developing an enzymatic DNA synthesis platform technology, enabling new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, data storage, nanotechnology and more. Molecular Assemblies’ novel enzymatic DNA synthesis platform has the potential to fundamentally transform how we write genetic building blocks with applications across food, healthcare, energy, and beyond. Learn more…

Company Website

Healionics, Inc.

Healionics, Inc. has developed a novel bio-material called STAR, that features strong anti-infective properties and significant reduction in the formation of scar tissue around implanted medical devices coated with the material. Learn more…

Company Website

Holobiome, Inc.

Holobiome is developing a platform for microbiome-based therapeutics to treat diseases of the central and enteric nervous systems.  Learn more…

Company Website

SciBac, Inc.

SciBac is developing a platform technology called MERGE that enables the Company to efficiently combine desired traits of two microbes into one stable hybrid organism through lab-induced directed evolution. Learn more…

Company Website

GeneMatters, LLC

GeneMatters is a digital health platform that provides scalable, on-demand genetic counseling to meet the rapidly growing demand for genetic services. Learn more…

Company Website

Flywheel Exchange, LLC

Flywheel offers a SaaS platform that provides cloud-scale data management and computational analysis. Learn more…

Company Website

Cofactor Genomics, Inc.

Cofactor Genomics uses proprietary RNA sequencing (“RNA-Seq”) technology and machine learning algorithms to diagnose disease. Learn more…

Company Website

Entac Medical, Inc.

Entac Medical is developing noninvasive devices for predictive and diagnostic medicine based on a novel, patented, platform technology, Previs Audio Spectral Analysis. Their first product is used to predict post operative ileus after GI surgeries. Learn more…

Company Website

Indalo Therapeutics

Indalo Therapeutics is developing novel small-molecule therapeutics to differentially treat and prevent the rapidly growing class of fibrotic diseases affecting millions globally. Learn more…

Company Website

Gila Therapeutics, Inc.

Gila Therapeutics is developing a treatment for obesity using naturally occurring hormones known to induce satiety, leading to weight loss. Learn more…

Company Website

Euclises Pharmaceuticals, Inc.

Euclises Pharmaceuticals is developing novel enzyme (COX-2) inhibitors designed to increase the effectiveness of chemotherapy safely Learn more…

Company Website

Immunophotonics, Inc.

Immunophotonics has developed a minimally invasive therapeutic cancer vaccine for the treatment of metastatic solid tumors. Learn more…

Company Website

Meet Our Selection Committee

Our Healthcare Selection Committee consists of industry and subject matter experts who help guide iSelect’s investment decisions. With firsthand experience and a true pulse on the industry, we consider these individuals key to our success in finding and investing in healthcare innovation.

Tiffany Osborn

Read full bio >

Ruchir Sehra, M

Read full bio >

Surekha Trivedi

Read full bio >

Jill Davies is

Read full bio >

Vice President

Read full bio >

Jin-Moo Lee, MD

Read full bio >

Emily Fassi is

Read full bio >

Dr. David Messi

Read full bio >

Dr. Bruce Germa

Read full bio >

Jean Roberson

Jean Roberson i

Read full bio >

A regulatory pr

Read full bio >

Andrew Daniels

Andy Daniels is

Read full bio >

Dr. Paul D. Oli

Read full bio >

Bobby Sandage

Bobby Sandage i

Read full bio >

Lila Solnica-Kr

Read full bio >

Gian Cavallini

Read full bio >

Don Imholz

Mr. Don Imholz

Read full bio >

Michael Beat

Presently leadi

Read full bio >

Mr. Beuttenmull

Read full bio >

Professor of In

Read full bio >

Dr. John Talley

Read full bio >

Bryce Rutter

Dr. Rutter is f

Read full bio >

Mark has served

Read full bio >

Dr. Panagos is

Read full bio >

Before joining

Read full bio >

Dr. Raghavan br

Read full bio >

Edwards was emp

Read full bio >

Michael Nichols

Michael Nichols

Read full bio >

David Christenson

David Christens

Read full bio >

Professor of Me

Read full bio >

Renaldo Cataldo

An accomplished

Read full bio >

Join Our Healthcare Innovation Network

Join the thousands of entrepreneurs, investors, and industry professionals driving the future of healthcare.

Resources and News

Investing at the Nexus of Food and Health

Investing at the Nexus of Food and Health

Almost three years ago, iSelect strategically refocused its investment thesis on identifying the synergies between food and healthcare. At the time, food and healthcare were two completely independent, siloed verticals. But, the fact is, the more that we understand...

read more
System C: The Convergence of Food and Health

System C: The Convergence of Food and Health

We’re here to talk about food system innovation. When we first started this conference, we talked about agtech, and as investors we also focus on healthcare and the convergence of healthcare and agriculture. Innovation is now being discussed as food system innovation. And, so we’ve invited you all and eager to have you participate in the conversation about how we make food improve health and life.

read more
How Blood-Based Diagnostics are Changing Cancer Care

How Blood-Based Diagnostics are Changing Cancer Care

iSelect hosts a Deep Dive webinar on a novel innovation topic on the first and third Wednesdays of each month at 9 a.m. central. Our most recent session focused on early cancer diagnosis using blood-based tools. Testing patients for cancer has typically involved a...

read more
What’s the Future of Nutrition? Addiction

What’s the Future of Nutrition? Addiction

The modern world has a serious problem with sugar. The average American consumes more than 129 pounds of the stuff each year, according to the USDA, more than double what we ate two generations ago. And, unlike in previous decades when most sweeteners came from cane...

read more
4 Trends We’re Watching in Healthcare in 2019

4 Trends We’re Watching in Healthcare in 2019

Healthcare is massive economic burden in this country. According to the National Health Expenditure Accounts, the federal agency that has tracked healthcare spending in the U.S. since the 1960s, it now totals roughly $3.5 trillion per year, or more than $10,000 per person. As a percentage of GDP, health spending accounts for nearly 18%.

read more
2 Companies That Are Working to Cure Cancer Right Now

2 Companies That Are Working to Cure Cancer Right Now

In 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people died as a result of the disease, according to the National Cancer Institute. These numbers are staggering. The challenge for clinicians and researchers is...

read more